JP5923238B2 - 迷走神経活性化剤 - Google Patents

迷走神経活性化剤 Download PDF

Info

Publication number
JP5923238B2
JP5923238B2 JP2010154893A JP2010154893A JP5923238B2 JP 5923238 B2 JP5923238 B2 JP 5923238B2 JP 2010154893 A JP2010154893 A JP 2010154893A JP 2010154893 A JP2010154893 A JP 2010154893A JP 5923238 B2 JP5923238 B2 JP 5923238B2
Authority
JP
Japan
Prior art keywords
lactic acid
vagus nerve
acid bacteria
activator
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2010154893A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012017282A (ja
JP2012017282A5 (enExample
Inventor
澤田　大輔
大輔 澤田
茂 藤原
茂 藤原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Group Holdings Ltd
Original Assignee
Asahi Group Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Group Holdings Ltd filed Critical Asahi Group Holdings Ltd
Priority to JP2010154893A priority Critical patent/JP5923238B2/ja
Priority to US13/177,138 priority patent/US20120009163A1/en
Priority to CA2745341A priority patent/CA2745341C/en
Publication of JP2012017282A publication Critical patent/JP2012017282A/ja
Publication of JP2012017282A5 publication Critical patent/JP2012017282A5/ja
Priority to US13/975,831 priority patent/US20130336943A1/en
Application granted granted Critical
Publication of JP5923238B2 publication Critical patent/JP5923238B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Animal Husbandry (AREA)
  • Physiology (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)
JP2010154893A 2010-07-07 2010-07-07 迷走神経活性化剤 Active JP5923238B2 (ja)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2010154893A JP5923238B2 (ja) 2010-07-07 2010-07-07 迷走神経活性化剤
US13/177,138 US20120009163A1 (en) 2010-07-07 2011-07-06 Means and methods for activating vagus nerve
CA2745341A CA2745341C (en) 2010-07-07 2011-07-06 Means and methods for activating vagus nerve
US13/975,831 US20130336943A1 (en) 2010-07-07 2013-08-26 Means and methods for activating vagus nerve

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010154893A JP5923238B2 (ja) 2010-07-07 2010-07-07 迷走神経活性化剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014263059A Division JP5950993B2 (ja) 2014-12-25 2014-12-25 迷走神経活性化剤

Publications (3)

Publication Number Publication Date
JP2012017282A JP2012017282A (ja) 2012-01-26
JP2012017282A5 JP2012017282A5 (enExample) 2013-05-09
JP5923238B2 true JP5923238B2 (ja) 2016-05-24

Family

ID=45438733

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010154893A Active JP5923238B2 (ja) 2010-07-07 2010-07-07 迷走神経活性化剤

Country Status (3)

Country Link
US (2) US20120009163A1 (enExample)
JP (1) JP5923238B2 (enExample)
CA (1) CA2745341C (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5943342B2 (ja) * 2012-03-02 2016-07-05 国立研究開発法人産業技術総合研究所 概日リズム改善剤
JP6067292B2 (ja) * 2012-03-19 2017-01-25 サッポロビール株式会社 セロトニン分泌促進剤
EP2881459B1 (en) * 2012-07-31 2025-06-25 Kaneka Corporation Novel Enterococcus faecium Strains
CA2890507A1 (en) * 2012-11-16 2014-05-22 Calpis Co., Ltd. Agent for alleviating stress-induced bowel disorder containing specific lactobacillus gasseri strain or treated product threof
JP6214162B2 (ja) * 2012-11-16 2017-10-18 アサヒグループホールディングス株式会社 新規の低温耐性ラクトバチルス・ガセリ株
JP2014101288A (ja) * 2012-11-16 2014-06-05 Calpis Co Ltd ストレス性腸障害の抑制剤
JP6053466B2 (ja) * 2012-11-16 2016-12-27 アサヒグループホールディングス株式会社 ストレス性下痢の抑制剤
US10039798B2 (en) * 2013-11-13 2018-08-07 In Ingredients, Inc. Extracts of rosemary or hemerocallis fulva and methods of using same to promote circadian rhythm
EP3124031B1 (en) * 2014-03-25 2020-12-30 Kabushiki Kaisha Yakult Honsha Sleep quality improver
KR101720681B1 (ko) * 2014-11-26 2017-04-03 고려대학교 산학협력단 호프 추출물을 포함하는 수면 촉진용 조성물
WO2017033925A1 (ja) * 2015-08-24 2017-03-02 株式会社ヤクルト本社 酪酸産生菌
JP6654639B2 (ja) * 2015-09-18 2020-02-26 国立大学法人徳島大学 血中トリプトファン濃度上昇抑制剤
JP6820340B2 (ja) * 2015-12-17 2021-01-27 シージェイ チェルジェダン コーポレイション 腸内生存率が高められた乳酸菌のコーティング方法
US10925906B2 (en) 2016-04-13 2021-02-23 Meiji Co., Ltd. Composition for improving brain function for neonates
CN108495558A (zh) * 2016-04-20 2018-09-04 株式会社明治 疲劳感改善用发酵乳
AU2017287987B2 (en) 2016-06-30 2024-08-01 Asahi Group Holdings, Ltd. Cartilage regeneration facilitating composition
JP6923883B2 (ja) * 2016-06-30 2021-08-25 アサヒグループホールディングス株式会社 栄養状態改善に使用するための組成物
JP6994116B2 (ja) * 2018-02-02 2022-02-04 コバイオラブス，インコーポレーテッド ラクトバチルスプランタルムｋｂｌ３９６菌株およびその用途
JP2019156721A (ja) * 2018-03-07 2019-09-19 フタムラ化学株式会社 血流改善用可食組成物
US20210352925A1 (en) * 2019-02-04 2021-11-18 N.V. Nutricia Fermented formula with non digestible oligosaccharides for sleep improvement
JP7369992B2 (ja) * 2019-05-13 2023-10-27 株式会社明治 自律神経機能改善用の発酵乳
CN111034761A (zh) * 2019-12-23 2020-04-21 江西普正制药股份有限公司 一种杜仲饼干及其制备方法
JP2021123561A (ja) * 2020-02-05 2021-08-30 雪印メグミルク株式会社 睡眠促進用組成物及び組成物を含む食品、医薬品、飼料
WO2021157435A1 (ja) * 2020-02-05 2021-08-12 雪印メグミルク株式会社 睡眠促進用組成物及び組成物を含む食品、医薬品、飼料
JP2021123562A (ja) * 2020-02-05 2021-08-30 雪印メグミルク株式会社 睡眠促進用組成物及び組成物を含む食品、医薬品、飼料
JP7593740B2 (ja) * 2020-03-02 2024-12-03 株式会社明治 睡眠の質改善用組成物、全体的健康感改善用組成物および活力向上用組成物
CN111826324A (zh) * 2020-08-05 2020-10-27 厦门惠盈动物科技有限公司 一种鼠李糖乳杆菌菌粉的制备方法
CN112106704A (zh) * 2020-10-28 2020-12-22 广东梁氏水产种业有限公司 蛭弧菌用于提高翘嘴鳜人工饲料驯食率的用途
WO2022115907A1 (en) * 2020-12-01 2022-06-09 Servatus Ltd Methods for improving sleep quality
JPWO2023234166A1 (enExample) * 2022-06-01 2023-12-07
TW202506147A (zh) * 2023-04-28 2025-02-16 日商東亞藥品工業股份有限公司 神經幹細胞之增殖、分化、成熟之促進、小神經膠質細胞之活化促進及星狀細胞之活化促進用組成物、以及記憶力及/或學習能力之維持及/或提升用組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3046303B1 (ja) * 1999-06-24 2000-05-29 明治乳業株式会社 Ｈｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉ除菌性飲食品
US6444203B2 (en) * 1999-12-20 2002-09-03 Compagnie Gervais Danone Administering bacteria to improve sleep
USRE48652E1 (en) * 2006-08-04 2021-07-20 Bioneer Corporation Lactic acid bacteria isolated from mother's milk with probiotic activity and inhibitory activity against body weight augmentation
JP2008214253A (ja) * 2007-03-02 2008-09-18 Snow Brand Milk Prod Co Ltd 内臓脂肪減少剤
EP2143427A1 (en) * 2007-03-30 2010-01-13 Suntory Holdings Limited Medicinal composition, food or drink having effect of enhancing parasympathetic nervous actions
US8259163B2 (en) * 2008-03-07 2012-09-04 Intellectual Ventures Holding 67 Llc Display with built in 3D sensing
AU2009319257B2 (en) * 2008-11-03 2014-10-09 Société des Produits Nestlé S.A. A nutritional composition comprising probiotics and improving sleep patterns
JP5155961B2 (ja) * 2009-07-17 2013-03-06 雪印メグミルク株式会社 加齢に伴う代謝異常症の予防・改善・治療剤

Also Published As

Publication number Publication date
JP2012017282A (ja) 2012-01-26
US20120009163A1 (en) 2012-01-12
CA2745341C (en) 2018-01-16
CA2745341A1 (en) 2012-01-07
US20130336943A1 (en) 2013-12-19

Similar Documents

Publication Publication Date Title
JP5923238B2 (ja) 迷走神経活性化剤
AU2011262840B2 (en) Lipid metabolism-improving agent
JP5686680B2 (ja) 乳酸菌発酵によるカゼイン由来ペプチドの製造方法
JP5840368B2 (ja) 関節炎予防改善用物質
AU2017287989B2 (en) Composition for use in improvement of nutritional state
JPWO2013084971A1 (ja) 乳酸菌又はその処理物を含む脂質代謝及び／又は糖代謝改善剤
JPWO2012063826A1 (ja) 高タンパク質分解活性を有するラクトバチルス・ヘルベティカス菌
AU2017287988B2 (en) Renal anemia ameliorating composition
JP5836928B2 (ja) 大腸におけるビフィズス菌の増加及び減少抑制剤
JP5950993B2 (ja) 迷走神経活性化剤
EP3479836B1 (en) Cartilage regeneration facilitating composition
AU2015201076B2 (en) Lipid metabolism-improving agent

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130116

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130326

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140304

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140507

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20141007

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141225

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20150107

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20150130

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20160129

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160418

R150 Certificate of patent or registration of utility model

Ref document number: 5923238

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250